{"podcast":{"title":"from Dreamers to Disruptors","slug":"from-dreamers-to-disruptors-7329003","podcast_index_feed_id":7329003,"rss_url":"https://media.rss.com/from-dreamers-to-disruptors/feed.xml","website_url":"https://rss.com/podcasts/from-dreamers-to-disruptors","image_url":"https://media.rss.com/from-dreamers-to-disruptors/20250509_090518_5f22b7c3b5016d78d606bc840d8a73d9.png","author":"Medidata","episode_count":14,"summary":"This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors , a podcast by Medidata.","last_synced_at":"2026-07-14T08:20:02.059953+00:00","page_url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003"},"episode":{"title":"How Drug Repurposing Unlocks New Uses for Existing Medicines: Every Cure’s David Fajgenbaum","slug":"how-drug-repurposing-unlocks-new-uses-for-existing-medicines-every-cure-s-david-fajgenbaum","published_at":"2025-12-15T20:44:27+00:00","page_url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/how-drug-repurposing-unlocks-new-uses-for-existing-medicines-every-cure-s-david-fajgenbaum","show_page_url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003","url":"https://rss.com/podcasts/from-dreamers-to-disruptors/2392871","audio_url":"https://content.rss.com/episodes/329244/2392871/from-dreamers-to-disruptors/2025_12_15_20_36_00_9e2631ad-d075-4d07-9235-74a3ea702fd1.mp3","summary":"David Fajgenbaum’s relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Castleman disease and running out of treatment options, David used his research skills to identify an existing drug that saved his life. Join David and Medidata CEO Anthony Costello to explore the origins of Every Cure—and how David’s experience became the seed for a nonprofit that uncovers life-changing uses for treatments already approved for other conditions. Discover Every Cure’s innovative approaches to data, the scope of unmet needs across healthcare, and how pharmaceutical companies can contribute to a future where we unlock the full potential of treatments for all. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow David: LinkedIn","meta_description":"David Fajgenbaum’s relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Ca…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2913,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/how-drug-repurposing-unlocks-new-uses-for-existing-medicines-every-cure-s-david-fajgenbaum/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/how-drug-repurposing-unlocks-new-uses-for-existing-medicines-every-cure-s-david-fajgenbaum.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}